Survival of women ages 40-49 years with breast carcinoma according to method of detection

Cancer

Volumn 79, Issue 10, 1997, Pages 1923-1932

  McPherson, Carol P ^a   Swenson, Karen K ^a   Jolitz, Gail ^b   Murray, Charles L ^a,c  

^a Institute for Research and Education   (United States)

^b TUMORS   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

breast carcinoma detection; breast neoplasm; mammography for women ages 40 49 years; prognostic factors; screening; survival

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOMA; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADULT; BIAS (EPIDEMIOLOGY); BREAST NEOPLASMS; BREAST SELF-EXAMINATION; CARCINOMA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM INVASIVENESS; PHYSICAL EXAMINATION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 0030918228     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970515)79:10<1923::AID-CNCR13>3.0.CO;2-X     Document Type: Article

References (32)

1. Feig S. Mammography screening: published guidelines and actual practice. Recent Results Cancer Res 1987; 105:78-88.
2. Mettlin C, Dodd GD. The American Cancer Society guidelines for the cancer-related checkup: an update. CA Cancer J Clin 1991; 41:279-82.
3. Volkers N. NCI replaces guidelines with statement of evidence. J Natl Cancer Inst 1994; 86:14-5.
4. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 1993; 85:1644-56.
5. Alexander FE, Anderson TJ, Brown HK, Forrest APM, Hepburn W, Kirkpatrick AE, et al. The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer 1994; 70:542-8.
6. Frisell J, Eklund G, Hellstrom L, Lidbrink E, Rutqvist LE, Somell A. Randomized study of mammographic screening: preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 1991; 18:49-56.
7. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988; 297:943-8.
8. Tabar L, Gad A, Holmberg LH, Ljungquist U, Fagerberg CJG, Baldetorp L, et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985; 1(8433):829-32.
9. Chu KC, Smart CR, Tarone RE. Analysis of breast cancer mortality and stage-distribution by age for the Health Insurance Clinical Trial. J Natl Cancer Inst 1988; 80:1125-32.
10. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years [published erratum appears in Can Med Assoc J 1993; 148:718]. Can Med Assoc J 1992; 147:1459-76.
11. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 40 to 49 years [published erratum appears in Can Med Assoc J 1993; 148:718]. Can Med Assoc J 1992; 147:1477-88.
12. Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Rydén S, et al. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet 1993; 341:973-8.
13. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography: a meta-analysis. JAMA 1995; 273:149-54.
14. Smart CR, Hendrick RE, Rutledge JH, Smith RA. Benefit of mammography screening in women ages 40 to 49 years [published erratum appears in Cancer 1995; 75:2788]. Cancer 1995; 75:1619-26.
15. Tarone RE. The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer 1995; 75:997-1003.
16. Tabar L, Fagerberg G, Chen H, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age. Cancer 1995; 75:2507-17.
17. Moskowitz M. Breast cancer: age-specific growth rates and screening strategies. Radiology 1986; 161:37-41.
18. Pelikan S, Moskowitz M. Effects of lead time, length bias, and false-negative assurance on screening for breast cancer. Cancer 1993; 71:1998-2005.
19. Feig SA. Determination of mammographic screening intervals with surrogate measures for women aged 40-49 years. Radiology 1994; 193:311-4.
20. Tabar L, Faberberg G, Day NE, Holmberg L. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer 1987; 55:547-51.
21. Kopans DB, Halpern E, Hulka CA. Statistical power in breast cancer screening trials and mortality reduction among women 40-49 years of age with particular emphasis on the National Breast Screening Study of Canada [commentary]. Cancer 1994; 74:1196-1203.
22. Stacey-Clear A, McCarthy KA, Hall DA, Pile-Spellman E, White G, Hulka C, et al. Breast cancer survival among women under age 50: is mammography detrimental? Lancet 1992; 340:991-4.
23. de Konig HJ, Boer R, Warmerdam PG, Beemsterboer PMM, van der Maas PJ. Quantitative interpretation of age-specific mortality reductions from these Swedish Breast Cancer-Screening Trials. J Natl Cancer Inst 1995; 87:1217-23.
24. Feig SA. Estimation of currently attainable benefit from mammographic screening of women aged 40-49 years. Cancer 1995; 75;2412-9.
25. SAS Institute Inc. SAS/STAT User's Guide. Version 6. Fourth Edition. Volume 2. Cary, NC: SAS Institute Inc. 1989.
26. Surveillance Program, Division of Cancer Prevention and Control, National Cancer Institute. Bethesda, MD: National Institutes of Health, 1995.
27. Mettlin C, Smart CR. Breast cancer detection guidelines for women aged 40 to 49 years: rationale for the American Cancer Society reaffirmation of recommendations. CA Cancer J Clin 1994; 44:248-55.
28. Brekelmans CTM, Peeters PHM, Faber JAJ, Deurenberg JJM, Collette HJA. The epidemiological profile of women with an interval cancer in the DOM screening programme. Breast Cancer Res Treat 1994; 30:223-32.
29. Ikeda DM, Andersson I, Wattsgard C, Janzon L, Linell F. Interval carcinomas in the Malmö Mammographic Screening Trials. Am J Roentgenol 1992; 159:287-94.
30. von Rosen A, Frisell J, Nilsson R, Wiege M, Auer G. Histopathologic and cytochemical characteristics of interval breast carcinomas from the Stockholm mammography screening project. Acta Oncol 1992; 31:399-402.
31. Lindfors KK, Rosenquist J. The cost-effectiveness of mammographic screening strategies. JAMA 1995; 274: 881-4.
32. Kopans DB. Conventional wisdom: observation, experience, anecdote, and science in breast imaging. Am J Roentgenol 1994; 162:299-303.